Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lessells RJ"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 35
Tytuł:
Scale-up of a decentralized HIV treatment programme in rural KwaZulu-Natal, South Africa: does rapid expansion affect patient outcomes?
Autorzy:
Mutevedzi PC (AUTHOR)
Lessells RJ (AUTHOR)
Heller T (AUTHOR)
Bärnighausen T (AUTHOR)
Cooke GS (AUTHOR)
Newell M (AUTHOR)
Pokaż więcej
Źródło:
Bulletin of the World Health Organization. Aug2010, Vol. 88 Issue 8, p593-600. 8p.
URL:
52929643  Link otwiera się w nowym oknie
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Clinical Outcomes After Viremia Among People Receiving Dolutegravir vs Efavirenz-Based First-line Antiretroviral Therapy in South Africa.
Autorzy:
Asare K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Lewis L; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.
van der Molen J; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.
Sookrajh Y; eThekwini Municipality Health Unit, eThekwini Municipality, Durban, KwaZulu-Natal, South Africa.
Khubone T; eThekwini Municipality Health Unit, eThekwini Municipality, Durban, KwaZulu-Natal, South Africa.
Moodley P; Department of Virology, University of KwaZulu-Natal and National Health Laboratory Service, Inkosi Albert Luthuli Central Hospital, Durban, KwaZulu-Natal, South Africa.
Lessells RJ; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.; KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Naidoo K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.; South African Medical Research Council (SAMRC)-CAPRISA-TB-HIV Pathogenesis and Treatment Research Unit, University of KwaZulu-Natal Nelson R Mandela School of Medicine, Durban, KwaZulu-Natal, South Africa.
Sosibo P; eThekwini Municipality Health Unit, eThekwini Municipality, Durban, KwaZulu-Natal, South Africa.
Garrett N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.
Dorward J; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, KwaZulu-Natal, South Africa.; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxfordshire, UK.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2023 Nov 16; Vol. 10 (12), pp. ofad583. Date of Electronic Publication: 2023 Nov 16 (Print Publication: 2023).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of miniaturized Illumina DNA preparation protocols for SARS-CoV-2 whole genome sequencing.
Autorzy:
Pillay S; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
San JE; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Tshiabuila D; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Naidoo Y; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Pillay Y; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Maharaj A; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Anyaneji UJ; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Wilkinson E; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Tegally H; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.
Lessells RJ; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Center for AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Baxter C; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.; Center for AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
de Oliveira T; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.; Center for AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.; Department of Global Health, University of Washington, Seattle, WA, United States of America.
Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Apr 26; Vol. 18 (4), pp. e0283219. Date of Electronic Publication: 2023 Apr 26 (Print Publication: 2023).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
SARS-CoV-2*/genetics
COVID-19*
Humans ; Whole Genome Sequencing/methods ; High-Throughput Nucleotide Sequencing/methods ; Gene Library
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
SARS-CoV-2 Genetic Diversity and Lineage Dynamics in Egypt during the First 18 Months of the Pandemic.
Autorzy:
Roshdy WH; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
Khalifa MK; Omicsense, Cairo 11799, Egypt.
San JE; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.
Tegally H; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch 7600, South Africa.
Wilkinson E; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch 7600, South Africa.
Showky S; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
Martin DP; Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory, Cape Town 7700, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town, Observatory, Cape Town 7700, South Africa.
Moir M; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch 7600, South Africa.
Naguib A; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
Elguindy N; Central Public Health Laboratory, Ministry of Health and Population, Cairo 11613, Egypt.
Gomaa MR; Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Dokki, Giza 12622, Egypt.
Fahim M; Department of Surveillance and Epidemiology, Ministry of Health and Population, Cairo 12622, Egypt.
Abu Elsood H; Department of Surveillance and Epidemiology, Ministry of Health and Population, Cairo 12622, Egypt.
Mohsen A; World Health Organization, Egypt Country Office, Cairo 12622, Egypt.
Galal R; Public Health Initiative, Cairo 11613, Egypt.
Hassany M; National Hepatology and Tropical Medicine Research Institute, Ministry of Health and Population, Cairo 11613, Egypt.
Lessells RJ; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.
Al-Karmalawy AA; Department of Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
El-Shesheny R; Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Dokki, Giza 12622, Egypt.
Kandeil AM; Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Dokki, Giza 12622, Egypt.
Ali MA; Centre of Scientific Excellence for Influenza Viruses, National Research Centre, Dokki, Giza 12622, Egypt.
de Oliveira T; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban 4001, South Africa.; Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch 7600, South Africa.; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Aug 25; Vol. 14 (9). Date of Electronic Publication: 2022 Aug 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/epidemiology
SARS-CoV-2*/genetics
Egypt/epidemiology ; Humans ; Mutation ; Pandemics ; Phylogeny
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Acquired HIV drug resistance and virologic monitoring in a HIV hyper-endemic setting in KwaZulu-Natal Province, South Africa.
Autorzy:
Chimukangara B; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa. .; Department of Virology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa. .; Critical Care Medicine Department, NIH Clinical Center, Bethesda, MD, USA. .
Lessells RJ; KwaZulu-Natal Research and Innovation Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Doris Duke Medical Research Institute, Durban, South Africa.
Singh L; KwaZulu-Natal Research and Innovation Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Doris Duke Medical Research Institute, Durban, South Africa.
Grigalionyte I; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Yende-Zuma N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; South African Medical Research Council (SAMRC), CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
Adams R; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Dawood H; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; Infectious Diseases, Department of Medicine, Greys Hospital, Durban, South Africa.
Dlamini L; National Department of Health, Pretoria, South Africa.
Buthelezi S; East Boom Community Health Centre, Pietermaritzburg, South Africa.
Chetty S; East Boom Community Health Centre, Pietermaritzburg, South Africa.
Diallo K; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Pretoria, South Africa.
Duffus WA; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Pretoria, South Africa.
Mogashoa M; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Pretoria, South Africa.
Hagen MB; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Pretoria, South Africa.
Giandhari J; KwaZulu-Natal Research and Innovation Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Doris Duke Medical Research Institute, Durban, South Africa.
de Oliveira T; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; KwaZulu-Natal Research and Innovation Platform (KRISP), College of Health Sciences, University of KwaZulu-Natal, Doris Duke Medical Research Institute, Durban, South Africa.
Moodley P; Department of Virology, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal and National Health Laboratory Service, Durban, South Africa.
Padayatchi N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.
Naidoo K; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa.; South African Medical Research Council (SAMRC), CAPRISA HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2021 Oct 16; Vol. 18 (1), pp. 74. Date of Electronic Publication: 2021 Oct 16.
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Adult ; Cross-Sectional Studies ; Drug Resistance ; Drug Resistance, Viral/genetics ; Humans ; Lamivudine/therapeutic use ; South Africa/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Emtricitabine-induced pure red cell aplasia.
Autorzy:
Manickchund N; King Edward VIII Hospital, Durban, South Africa.; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
du Plessis C; King Edward VIII Hospital, Durban, South Africa.; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
John MA; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
Manzini TC; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
Gosnell BI; King Edward VIII Hospital, Durban, South Africa.; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
Lessells RJ; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.; KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa.; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
Moosa YS; King Edward VIII Hospital, Durban, South Africa.; Department of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.
Pokaż więcej
Źródło:
Southern African journal of HIV medicine [South Afr J HIV Med] 2019 Sep 23; Vol. 20 (1), pp. 983. Date of Electronic Publication: 2019 Sep 23 (Print Publication: 2019).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges.
Autorzy:
Lessells RJ; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, PO Box 198, Mtubatuba, KwaZulu-Natal 3935, South Africa. .
Stott KE
Manasa J
Naidu KK
Skingsley A
Rossouw T
de Oliveira T
Pokaż więcej
Corporate Authors:
Southern African Treatment and Resistance Network (SATuRN)
Źródło:
BMC health services research [BMC Health Serv Res] 2014 Mar 07; Vol. 14, pp. 116. Date of Electronic Publication: 2014 Mar 07.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Microbial Sensitivity Tests*/methods
Anti-HIV Agents/*therapeutic use
HIV Infections/*drug therapy
Adult ; Anti-HIV Agents/administration & dosage ; Drug Resistance, Viral ; Female ; Genotype ; HIV Infections/virology ; HIV-1/drug effects ; HIV-1/genetics ; Humans ; Male ; Primary Health Care/organization & administration ; Rural Health Services/organization & administration ; South Africa/epidemiology ; Treatment Failure
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort.
Autorzy:
Pillay S
Bland RM
Lessells RJ
Manasa J
de Oliveira T
Danaviah S; Africa Centre for Health and Population Studies, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa. .
Pokaż więcej
Źródło:
AIDS research and therapy [AIDS Res Ther] 2014 Jan 20; Vol. 11 (1), pp. 3. Date of Electronic Publication: 2014 Jan 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
High-levels of acquired drug resistance in adult patients failing first-line antiretroviral therapy in a rural HIV treatment programme in KwaZulu-Natal, South Africa.
Autorzy:
Manasa J; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa.
Lessells RJ
Skingsley A
Naidu KK
Newell ML
McGrath N
de Oliveira T
Pokaż więcej
Corporate Authors:
Southern African Treatment and Resistance Network
Źródło:
PloS one [PLoS One] 2013 Aug 21; Vol. 8 (8), pp. e72152. Date of Electronic Publication: 2013 Aug 21 (Print Publication: 2013).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Anti-HIV Agents/*therapeutic use
Drug Resistance, Viral/*drug effects
HIV Infections/*drug therapy
HIV-1/*drug effects
Adolescent ; Adult ; Alkynes ; Analysis of Variance ; Anti-HIV Agents/pharmacology ; Benzoxazines/pharmacology ; Benzoxazines/therapeutic use ; Cross-Sectional Studies ; Cyclopropanes ; Drug Resistance, Viral/genetics ; Drug Therapy, Combination ; Female ; Genotype ; HIV Infections/epidemiology ; HIV Infections/virology ; HIV-1/genetics ; Humans ; Lamivudine/pharmacology ; Lamivudine/therapeutic use ; Male ; Middle Aged ; Mutation ; Nevirapine/pharmacology ; Nevirapine/therapeutic use ; Outcome Assessment, Health Care ; Prevalence ; South Africa/epidemiology ; Stavudine/pharmacology ; Stavudine/therapeutic use ; Young Adult ; Zidovudine/pharmacology ; Zidovudine/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial.
Autorzy:
Iwuji CC; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, KwaZulu-Natal, South Africa. />Orne-Gliemann J
Tanser F
Boyer S
Lessells RJ
Lert F
Imrie J
Bärnighausen T
Rekacewicz C
Bazin B
Newell ML
Dabis F
Pokaż więcej
Corporate Authors:
ANRS 12249 TasP Study Group
Źródło:
Trials [Trials] 2013 Jul 23; Vol. 14, pp. 230. Date of Electronic Publication: 2013 Jul 23.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Guideline Adherence*
Practice Guidelines as Topic*
Research Design*
World Health Organization*
Anti-Retroviral Agents/*administration & dosage
HIV Infections/*drug therapy
Adolescent ; Adult ; Anti-Retroviral Agents/adverse effects ; Anti-Retroviral Agents/economics ; CD4 Lymphocyte Count ; Clinical Protocols ; Cost-Benefit Analysis ; Drug Administration Schedule ; Drug Costs ; Drug Resistance, Viral ; Feasibility Studies ; HIV Infections/diagnosis ; HIV Infections/economics ; HIV Infections/mortality ; HIV Infections/transmission ; HIV Infections/virology ; Health Knowledge, Attitudes, Practice ; Humans ; Incidence ; Medication Adherence ; Predictive Value of Tests ; Quality of Life ; Rural Health Services ; Sexual Behavior ; South Africa/epidemiology ; Time Factors ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Impact of a novel molecular TB diagnostic system in patients at high risk of TB mortality in rural South Africa (Uchwepheshe): study protocol for a cluster randomised trial.
Autorzy:
Lessells RJ; Department of Clinical Research, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK. richard.lessells@lshtm.ac.uk
Cooke GS
McGrath N
Nicol MP
Newell ML
Godfrey-Faussett P
Pokaż więcej
Źródło:
Trials [Trials] 2013 Jun 12; Vol. 14, pp. 170. Date of Electronic Publication: 2013 Jun 12.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Bacteriological Techniques*
Molecular Diagnostic Techniques*
Research Design*
Rural Health Services*
Mycobacterium tuberculosis/*isolation & purification
Tuberculosis, Multidrug-Resistant/*diagnosis
Tuberculosis, Pulmonary/*diagnosis
Ambulatory Care Facilities ; Antitubercular Agents/therapeutic use ; Clinical Protocols ; Coinfection ; HIV Infections/mortality ; Humans ; Laboratories ; Logistic Models ; Mycobacterium tuberculosis/growth & development ; Point-of-Care Systems ; Predictive Value of Tests ; Primary Health Care ; Risk Assessment ; Risk Factors ; South Africa/epidemiology ; Sputum/microbiology ; Time Factors ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/microbiology ; Tuberculosis, Multidrug-Resistant/mortality ; Tuberculosis, Pulmonary/drug therapy ; Tuberculosis, Pulmonary/microbiology ; Tuberculosis, Pulmonary/mortality
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Human resources needs for universal access to antiretroviral therapy in South Africa: a time and motion study.
Autorzy:
Hontelez JA; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa. .
Newell ML
Bland RM
Munnelly K
Lessells RJ
Bärnighausen T
Pokaż więcej
Źródło:
Human resources for health [Hum Resour Health] 2012 Oct 30; Vol. 10, pp. 39. Date of Electronic Publication: 2012 Oct 30.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
Autorzy:
Mutevedzi PC; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa. />Lessells RJ
Rodger AJ
Newell ML
Pokaż więcej
Źródło:
PloS one [PLoS One] 2011; Vol. 6 (7), pp. e21795. Date of Electronic Publication: 2011 Jul 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Anti-HIV Agents/*pharmacology
HIV Infections/*drug therapy
HIV Infections/*mortality
HIV-1/*drug effects
Rural Population/*statistics & numerical data
Adolescent ; Adult ; Age Distribution ; Anti-HIV Agents/therapeutic use ; CD4 Lymphocyte Count ; Cohort Studies ; Female ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/pathogenicity ; Humans ; Male ; Middle Aged ; South Africa ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The tuberculosis challenge in a rural South African HIV programme.
Autorzy:
Houlihan CF; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa. />Mutevedzi PC
Lessells RJ
Cooke GS
Tanser FC
Newell ML
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2010 Feb 10; Vol. 10, pp. 23. Date of Electronic Publication: 2010 Feb 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
AIDS-Related Opportunistic Infections/*epidemiology
HIV Infections/*complications
HIV Infections/*epidemiology
Tuberculosis/*epidemiology
AIDS-Related Opportunistic Infections/mortality ; Adolescent ; Adult ; CD4 Lymphocyte Count ; Female ; Humans ; Incidence ; Male ; Prevalence ; Risk Factors ; Rural Population ; Sex Factors ; South Africa/epidemiology ; Tuberculosis/mortality ; Viral Load ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 35

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies